EUVIMEDEUVIMED entdecken
Crossref

Early acute kidney injury after tacrolimus administration in heart transplant recipients receiving basiliximab induction therapy

Megumi Ikura, Tsutomu Nakamura, Kyoichi Wada, Rikako Nagata, Tomoko Ueno, Kazuyoshi Kawabata, Fumiki Yoshihara, Takuya Watanabe, Yasumasa Tsukamoto

Int. Journal of Clinical Pharmacology and Therapeutics · 2024

DOI: 10.5414/cp204586 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Int. Journal of Clinical Pharmacology and Therapeutics, 2024. Verfasst von Megumi Ikura und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: Basiliximab, Tacrolimus, Acute Kidney Injury, Immunosuppressive Agents.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BasiliximabTacrolimusAcute Kidney InjuryImmunosuppressive AgentsHeart TransplantationHumansMaleFemaleMiddle AgedRetrospective StudiesAdultGlomerular Filtration RateTime FactorsRecombinant Fusion ProteinsAged

Substanzen

BasiliximabTacrolimusImmunosuppressive AgentsRecombinant Fusion Proteins

Zitieren

APA

Ikura, M., Nakamura, T., Wada, K., Nagata, R., Ueno, T., Kawabata, K., Yoshihara, F., Watanabe, T., & Tsukamoto, Y. (2024). Early acute kidney injury after tacrolimus administration in heart transplant recipients receiving basiliximab induction therapy. Int. Journal of Clinical Pharmacology and Therapeutics. https://doi.org/10.5414/cp204586

Vancouver

Ikura M, Nakamura T, Wada K, Nagata R, Ueno T, Kawabata K, et al. Early acute kidney injury after tacrolimus administration in heart transplant recipients receiving basiliximab induction therapy. Int. Journal of Clinical Pharmacology and Therapeutics. 2024. doi:10.5414/cp204586

BibTeX
@article{Ikura2024,
  author = {Ikura, Megumi and Nakamura, Tsutomu and Wada, Kyoichi and Nagata, Rikako and Ueno, Tomoko and Kawabata, Kazuyoshi and Yoshihara, Fumiki and Watanabe, Takuya and Tsukamoto, Yasumasa},
  title = {Early acute kidney injury after tacrolimus administration in heart transplant recipients receiving basiliximab induction therapy},
  journal = {Int. Journal of Clinical Pharmacology and Therapeutics},
  year = {2024},
  doi = {10.5414/cp204586}
}
Kostenlos starten →